Hiroyuki Achiwa

Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas.

Toyoaki Hida, Yasushi Yatabe, Hiroyuki Achiwa et al. · PubMed · 1998 · 825 citations

Pathology, Cox-2 Expression, Cancer Biology +16

Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas.

Hiroyuki Achiwa, Yasushi Yatabe, Toyoaki Hida et al. · PubMed · 1999 · 317 citations

Elevated Cyclooxygenase 2, Lung Inflammation, Immunology +19

Determinants of sensitivity and resistance to gemcitabine: The roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non‐small cell lung cancer

Hiroyuki Achiwa, Tetsuya Oguri, Shigeki Sato et al. · Cancer Science · 2004 · 145 citations · Full text

MRP8/ABCC11 directly confers resistance to 5-fluorouracil

Tetsuya Oguri, Yuji Bessho, Hiroyuki Achiwa et al. · Molecular Cancer Therapeutics · 2007 · 130 citations

The determinants of sensitivity and acquired resistance to gemcitabine differ in non–small cell lung cancer: a role of <i>ABCC5</i> in gemcitabine sensitivity

Tetsuya Oguri, Hiroyuki Achiwa, Shigeki Sato et al. · Molecular Cancer Therapeutics · 2006 · 96 citations